Welcome to Labeled Immunoassays and Clinical Medicine website!

Research Development of Blood Tumor Marker in Early Diagnosis of Lung Cancer

  • 沈 迪,齐 军
Expand
  • Cancer Institute & Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 10021, China

Online published: 2013-11-01

Abstract

 Lung cancer is the most common cause of cancer death worldwide. Early diagnosis and early treatment are of great importance. Lung cancer is a multi-factorial disease, and multiple genes involved in the development of complex multi-stage process. In recent years, domestic and foreign scholars on the early diagnosis of lung cancer biomarkers have done a lot of useful exploration. In this paper, recent developments in this field are reviewed.

Cite this article

沈 迪,齐 军 . Research Development of Blood Tumor Marker in Early Diagnosis of Lung Cancer[J]. Labeled Immunoassays and Clinical Medicine, 2013 , 20(5) : 336 -347 . DOI: 10.11748/bjmy.issn.1006-1703.2013.05.017

Outlines

/